GSK-LSD1 2HCL

Names

[ Name ]:
GSK-LSD1 2HCL

[Synonym ]:
N-[(1R,2S)-2-Phenylcyclopropyl]-4-piperidinamine
4-Piperidinamine, N-[(1R,2S)-2-phenylcyclopropyl]-
GSK-LSD1 2HCL
GSK-LSD1 (hydrochloride)
LSD1 inhibitor

Biological Activity

[Description]:

GSK-LSD1 is a LSD1 inhibitor. GSK-LSD1 reduces food intake and body weight, and improves insulin sensitivity and glycemic control in mouse models of obesity. GSK-LSD1 also ameliorates NAFLD. GSK-LSD1 inhibits SARS-CoV-2-triggered cytokine release in COVID-19 PBMCs. GSK-LSD1 also inhibits cancer growth and metastasis[1][2][3].

[Related Catalog]:

Research Areas >> Cancer

Research Areas >> Infection

Signaling Pathways >> Epigenetics >> Histone Demethylase

Research Areas >> Metabolic Disease

[References]

[1]. Ramms B, et al. Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Diabetes. 2022 Dec 1;71(12):2513-2529.

[2]. Hong KS, et al. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 Nov 17;5(1):267.

[3]. Alsaqer SF, et al. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget. 2017 Jul 27;8(43):73372-73386.

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
347.4±42.0 °C at 760 mmHg

[ Molecular Formula ]:
C₁₄H₂₀N₂

[ Molecular Weight ]:
216.322

[ Flash Point ]:
206.0±19.7 °C

[ Exact Mass ]:
216.162643

[ LogP ]:
1.63

[ Appearance of Characters ]:
white to beige

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.580

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
H2O: soluble20mg/mL, clear

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.